Kainova Therapeutics Expands Phase I/II Trial of DT-7012, a Treg-depleting Anti-CCR8 Antibody, with First Patient Dosed in Europe

Recommended

Surge Copper Advances Berg Toward Pre-Feasibility with Successful 2025 Drilling and Data Validation Program

Cognitrex Inc. Announces Market Entry of Enterprise LearningOS Platform Led by Founder Hana Dhanji

Bombardier to Provide Six Multi-role Aircraft to Support the Royal Canadian Air Force